In nephrology, this may involve evaluating causal relationships, such as whether elevated serum uric acid levels are causally linked to the risk of developing CKD or whether increased fibroblast growth factor 23 (FGF23) levels affect cardiovascular mortality in patients with end-stage kidney disease (ESKD). Here, FGF23 is linked to chronic kidney disease.